WHO ICTRP trial
Impact of HIV and its treatment on reverse cholesterol transport
ACTRN12605000494639 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12605000494639 |
|---|---|
| Public title | Impact of HIV and its treatment on reverse cholesterol transport |
| Scientific title | Impact of HIV infection and treatment with Highly Active Antiretroviral therapy on Reverse Cholesterol Transport |
| Primary sponsor | National Health and Medical Research Council of Australia (grants # 317811 and 317810(DS) |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | HIV ;Atherosclerosis; HIV Atherosclerosis;Infection - Acquired immune deficiency syndrome (AIDS / HIV);Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system |
| Interventions | To compare untreated HIV-infected patients (patients who will not require therapy for the entire study duration of 12 months) with: HIV-infected patients that are PI naïve and initiating therapy with a protease inhibitor containing HAART… |
| Registration date | Sep 23, 2005 |
| Target size | 150 |
| Secondary IDs | nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: